A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...

Most of these lesions are benign or slow growing and the prognosis is significantly better than with pancreatic adenocarcinoma. However, some of these neoplasms slowly undergo malignant transformation ...

The lesion in the pancreatic tail was found to be benign, whereas the cytology of head lesion was reported as suspicious on first FNA and confirmed as adenocarcinoma on second FNA. Minor ...

Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in patients with KRAS G12D pancreatic ductal adenocarcinoma treated with ...

The Mayo research team found that the combination of cytology and FISH raised the detection rate of bile duct and pancreatic cancer from 20 percent to 43 percent. "Bile duct and pancreatic cancers ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

for evaluation of solid pancreatic lesions. Final diagnosis was based on a composite standard: histologic evidence at surgery, or non-equivocal malignant cytology on FNA and follow-up. The ...